Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.

Source:http://linkedlifedata.com/resource/pubmed/id/1412169

Thromb. Haemost. 1992 Aug 3 68 2 214-20

Download in:

View as

Triples

General Info

PMID
1412169